HIF1A and familial pancreatic carcinoma: MiR‐210 inhibits the expression of HOXA9 to activate the NF‐κB signaling, induces EMT, and reduces the sensitivity of pancreatic cancer cells to gemcitabine induced by HIF1A under hypoxia.23